Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Systemic Sclerosis, Scleroderma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04588714
What this trial is testing

Feasibility and Preliminary Effects of the Resilience-based, Energy Management to Enhance Wellbeing in Systemic Sclerosis (RENEW) Intervention

Who this might be right for
Scleroderma
University of Michigan 21
Large-scale testing (Phase 3)Study completedNCT00070590
What this trial is testing

Efficacy and Safety of Oral Bosentan in Pulmonary Fibrosis Associated With Scleroderma

Who this might be right for
Pulmonary FibrosisScleroderma, Systemic
Actelion 132
Early research (Phase 1)Study completedNCT06643390
What this trial is testing

MK-2225 in Healthy Participants (MK-2225-003)

Who this might be right for
Systemic Sclerosis
Merck Sharp & Dohme LLC 32
Very early researchLooking for participantsNCT07193810
What this trial is testing

CC312 for Relapsed/Refractory Autoimmune Diseases

Who this might be right for
SLE - Systemic Lupus ErythematosusIIM- Idiopathic Inflammatory MyopathiesSSc-Systemic Sclerosis
CytoCares Inc 6
Not applicableStudy completedNCT04854850
What this trial is testing

Apollo Device for Fatigue in Systemic Sclerosis

Who this might be right for
Systemic SclerosisFatigueRaynaud Phenomenon
Robyn T. Domsic, MD, MPH 25
Not applicableUnknownNCT05455437
What this trial is testing

Monitoring and Evaluation Study of Project ECHO for ILD

Who this might be right for
Interstitial Lung Diseases
Pulmonary Care and Research Collaborative Limited 200
Not applicableUnknownNCT01642706
What this trial is testing

Regulatory B Cells in Inflammatory Rheumatisms and Biomarkers of Response to Biologic Treatments

Who this might be right for
Rheumatoid ArthritisOsteoarthritisSystemic Lupus Erythematosus+6 more
University Hospital, Montpellier 240
Testing effectiveness (Phase 2)Study completedNCT04300426
What this trial is testing

Safety and Efficacy of Anaerobic Cultivated Human Intestinal Microbiome Transplantation in Systemic Sclerosis (ReSScue)

Who this might be right for
Systemic Sclerosis
Oslo University Hospital 75
Not applicableLooking for participantsNCT07251179
What this trial is testing

Characterization of Autoreactive b Lymphocytes in Autoimmune Diseases and Immune Deficiencies

Who this might be right for
Systemic Lupus ErythematosusSystemic SclerodermaANCA-associated Vasculitis+2 more
University Hospital, Strasbourg, France 200
Large-scale testing (Phase 3)Study completedNCT00004786
What this trial is testing

Phase III Randomized, Double-Blind, Placebo-Controlled Study of Oral Iloprost for Raynaud's Phenomenon Secondary to Systemic Sclerosis

Who this might be right for
Systemic SclerosisRaynaud Disease
National Center for Research Resources (NCRR) 200
Testing effectiveness (Phase 2)Looking for participantsNCT06733935
What this trial is testing

NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)

Who this might be right for
Systemic SclerosisIdiopathic Inflammatory MyopathiesAntineutrophil Cytoplasmic Antibody-Associated Vasculitis+1 more
Nkarta, Inc. 240
Testing effectiveness (Phase 2)Study completedNCT05559580
What this trial is testing

A Study in People With Systemic Sclerosis to Test Whether Avenciguat (BI 685509) Has an Effect on Lung Function and Other Systemic Sclerosis Symptoms

Who this might be right for
Scleroderma, Systemic
Boehringer Ingelheim 214
Not applicableStudy completedNCT04336475
What this trial is testing

The Effect of a Home-based Orofacial Exercise Program on Oral Aperture of Systemic Sclerosis Patients

Who this might be right for
MicrostomiaSystemic Sclerosis
Cukurova University 60
Post-approval studies (Phase 4)Study completedNCT07472166
What this trial is testing

Efficacy of Tofacitinib on Skin Thickening in Diffuse Cutaneous Systemic Sclerosis: A Comparative Study With Methotrexate

Who this might be right for
Scleroderma, Systemic
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh 34
Testing effectiveness (Phase 2)Study completedNCT01487551
What this trial is testing

An Open-Label Study to Evaluate Biomarkers and Safety in Systemic Sclerosis Patients Treated With ABR-215757 (Paquinimod)

Who this might be right for
Systemic Sclerosis
Active Biotech AB 9
Not applicableNot Yet RecruitingNCT06776575
What this trial is testing

Ultrasound and Electrophysiology Study of Hand in Systemic Sclerosis Patients and Contributors of Hand Dysfunction

Who this might be right for
SclerodermaHand FunctionalityQuality of Life (QOL)
Assiut University 45
Not applicableLooking for participantsNCT04334031
What this trial is testing

Deployment o the Multidisciplinary Prospective Cohort Imminent

Who this might be right for
Chronic Inflammatory DiseaseAngioedemaSevere Asthma+6 more
University Hospital, Lille 2,200
Testing effectiveness (Phase 2)Ended earlyNCT04837131
What this trial is testing

Evaluate the Safety and Tolerability of Oral Ixazomib in Scleroderma-related Lung Disease Patients

Who this might be right for
Systemic SclerosisSclerodermaDiffuse Systemic Sclerosis+16 more
Michael M. Pham 4
Not applicableStudy completedNCT04246528
What this trial is testing

SPIN Self-Management Feasibility Trial With Progression to Full-scale Trial (SPIN-SELF)

Who this might be right for
SclerodermaSystemic Sclerosis
Lady Davis Institute 169
Large-scale testing (Phase 3)Active Not RecruitingNCT05726630
What this trial is testing

Clinical Study of Divozilimab in Patients With Systemic Scleroderma

Who this might be right for
Systemic Scleroderma
Biocad 152
Next Page